ATAI Life Sciences BV (ATAI)

ATAI Life Sciences BV

ATAI

Date	Type	Insider	Position	Ø-Price	Volume
7/7/2026	Sell	Hershberg, Robert	Director	$5.0	$496,000
6/26/2026	Sell	Kochendoerfer, Gerd	Chief Operating Officer	$5.0	$250,000
6/25/2026	Sell	Craig, Kevin James	Chief Medical Officer	$4.5	$192,031
4/20/2026	Sell	Craig, Kevin James	Chief Medical Officer	$5.0	$212,895
3/20/2026	Sell	Craig, Kevin James	Chief Medical Officer	$3.6	$355,000
1/2/2026	Sell	Feilding-Mellen, Cosmo	Director	$3.9	$154,377
8/14/2025	Buy	Apeiron Investment Group Ltd.	Ten Percent Owner	$2.2	$19,000,000
3/24/2025	Buy	Apeiron Investment Group Ltd.	Ten Percent Owner	$1.4	$2,520,000
3/21/2025	Sell	Short, Glenn Frank	Chief Scientific Officer	$1.4	$17,767
3/21/2025	Sell	Johnson, Anne Nagengast	Chief Financial Officer	$1.4	$45,286
3/21/2025	Sell	Rao, Srinivas	Officer	$1.4	$101,814
3/21/2025	Sell	Craig, Kevin James	Chief Medical Officer	$1.4	$15,610
3/21/2025	Sell	Kirpekar, Sahil	Chief Business Officer	$1.4	$65,560
2/14/2025	Buy	Apeiron Investment Group Ltd.	Ten Percent Owner	$2.1	$22,755,008